u/Ok_Promotion3741

I'm looking for textbooks on cancer or pharmacology that focus on mechanism of action, efficacy signals, and biomarker identification

Can a member of the public leave a box of donuts and a flyer in the break room of a cancer center or oncology wing? Would an oncologist even see it?

I have nothing to sell but I am soliciting interviews as part of the NCI STEP training program to apply for federal grant funding

For any SBIR applicants who took an I-CORP program for a new therapuetic, what strategies did you use to contact customers?

I'm focused on oncologists, VCs, and researchers. I haven't had much luck making cold calls or through LinkedIn.

I'm a chemist and have to start interviewing doctors as part of an I-CORPs training class and I'm absolutely terrified of talking to anyone because I barely understand what they do.

I loved House MD as a kid and its a big part of why I made a career in science, but I imagine real doctors aren't burgling peoples homes and making offensive quips as much?

Where can I find more about what doctors do? How do they differ from oncologists, physicians, clinicians?

For cancer, what factors do doctors consider for choosing a line of treatment (cost, efficacy, mechanism)? How do they handle resistance when it develops and what do they wish could be improved?

https://doi.org/10.1016/j.ijpharm.2025.126373

https://www.sciencedirect.com/science/article/abs/pii/S0378517325012104?utm\_source=chatgpt.com

CEO presented a talk at a conference that disclosed our drug product by its development code (eg storm trooper type name) and its use in animal studies last year but provided no structure.

A press release disclosed that the drug product was administered in a clinical trial in Australia earlier this year, again only referring to the drugs code.

Do either of these events count as a disclosure that would begin our grace period? An examiner could find these documents on the Internet because our drug product is also referred to by a distinct trademarked name

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cplu.202600007

https://doi.org/10.1002/cplu.202600007

https://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.4c00595

https://doi.org/10.1021/acsmedchemlett.4c00595

https://www.sciencedirect.com/science/article/abs/pii/S2451965025000146

https://doi.org/10.1016/j.coemr.2025.100583

https://www.eurekaselect.com/article/105265

http://dx.doi.org/10.2174/0929867327666200316142659

MFSD2A in Focus: the Molecular Mechanism of Omega-3 Fatty Acid Transport | Physiology | American Physiological Society

https://doi.org/10.1152/physiol.00068.2024